Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 8, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	55	308	113	252	298	410
Market Cap Growth	28.06%	172.47%	-55.17%	-15.33%	-27.31%	95.57%
Enterprise Value	69	267	75	216	263	339
Last Close Price	1.28	7.32	2.75	9.16	11.51	15.89
PE Ratio	-	-4.95	-3.82	-7.05	-6.74	-14.03
PS Ratio	4.27	60.09	12.51	21.01	-	-
PB Ratio	-23.25	15.58	2.82	7.73	9.03	6.30
P/FCF Ratio	-4.69	-7.91	-5.96	-8.86	-9.40	-14.58
P/OCF Ratio	-4.71	-7.98	-6.06	-9.14	-9.86	-14.94
EV/Sales Ratio	4.96	52.19	8.32	17.98	-	-
EV/EBITDA Ratio	-3.96	-4.27	-3.61	-7.03	-6.55	-11.28
EV/EBIT Ratio	-3.92	-4.23	-3.53	-6.98	-6.54	-11.26
EV/FCF Ratio	-4.65	-6.87	-3.97	-7.58	-8.30	-12.06
Debt / Equity Ratio	-3.48	2.30	0.04	1.33	1.13	0.00
Debt / FCF Ratio	-0.70	-1.17	-0.08	-1.52	-1.17	-0.01
Asset Turnover	0.24	0.08	0.14	0.16	-	-
Quick Ratio	2.10	4.34	10.05	1.53	1.66	18.51
Current Ratio	2.36	4.55	11.31	1.61	1.71	19.39
Return on Equity (ROE)	-412.98%	-224.08%	-67.42%	-106.97%	-87.13%	-36.53%
Return on Assets (ROA)	-85.72%	-62.56%	-21.32%	-25.04%	-35.23%	-23.45%
Return on Capital (ROIC)	-109.04%	-73.97%	-22.64%	-26.42%	-37.10%	-24.32%
Earnings Yield	-159.17%	-21.76%	-21.67%	-13.92%	-14.34%	-6.89%
FCF Yield	-120.71%	-12.65%	-16.77%	-11.29%	-10.64%	-6.86%
Buyback Yield / Dilution	-8.69%	-32.72%	-26.32%	-8.20%	-0.39%	-69.80%
Total Shareholder Return	-8.69%	-32.72%	-26.32%	-8.20%	-0.39%	-69.80%

Source: S&P Capital IQ. Standard template. Financial Sources.